DBD — Diebold Nixdorf Income Statement
0.000.00%
Last trade - 00:00
- $1.20bn
- $1.91bn
- $3.76bn
- 68
- 98
- 94
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,409 | 3,902 | 3,905 | 3,461 | 3,761 |
Cost of Revenue | |||||
Gross Profit | 1,077 | 1,057 | 1,059 | 778 | 876 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,435 | 3,878 | 3,768 | 3,705 | 2,077 |
Operating Profit | -26.6 | 24 | 137 | -244 | 1,684 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -229 | -270 | -50.7 | -439 | 1,448 |
Provision for Income Taxes | |||||
Net Income After Taxes | -346 | -269 | -78.4 | -588 | 1,373 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -341 | -269 | -78.8 | -581 | 1,376 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -341 | -269 | -78.8 | -581 | 1,376 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.7 | -2.63 | -0.736 | -5.2 | 10.1 |
Dividends per Share |